A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis

SUMMARY STATEMENT: In subjects with active exudative age-related macular degeneration, treating with a fixed intravitreal aflibercept injection dosing regimen for 12 months demonstrated improved anatomic and vision endpoints from baseline. PURPOSE: Switching therapies in neovascular age-related macu...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Rishi P, Srivastava, Sunil K, Ehlers, Justis P, Silva, Fabiana Q, Bedi, Rumneek, Schachat, Andrew P, Kaiser, Peter K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590671/
https://www.ncbi.nlm.nih.gov/pubmed/26445522
http://dx.doi.org/10.2147/OPTH.S87043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590671/
https://www.ncbi.nlm.nih.gov/pubmed/26445522
http://dx.doi.org/10.2147/OPTH.S87043

Ejemplares similares